2024年9月13日至17日,2024年欧洲肿瘤内科学会(European Society for Medical Oncology,ESMO)年会在西班牙巴塞罗那召开。大会公布了多项肝细胞癌(hepatocellular carcinoma,HCC)领域的重磅研究,涵盖了早期、中期、晚期HCC的治疗进展,...2024年9月13日至17日,2024年欧洲肿瘤内科学会(European Society for Medical Oncology,ESMO)年会在西班牙巴塞罗那召开。大会公布了多项肝细胞癌(hepatocellular carcinoma,HCC)领域的重磅研究,涵盖了早期、中期、晚期HCC的治疗进展,包含系统治疗和局部治疗。这些研究将为HCC临床治疗提供新的方案并推动HCC治疗领域的发展。本文汇总此次大会的重点内容,并基于此探讨HCC相关治疗领域的问题及未来发展的方向。展开更多
2018年,欧洲肿瘤内科学会(European Society for Medical Oncology,ESMO)和日本、中国、韩国等亚洲各国胃癌治疗领域的专家以科学证据为基础,在胃癌诊疗方面达成共识,修订了2016年发布的《ESMO胃癌诊断、治疗和随访的临床实践指南》,以...2018年,欧洲肿瘤内科学会(European Society for Medical Oncology,ESMO)和日本、中国、韩国等亚洲各国胃癌治疗领域的专家以科学证据为基础,在胃癌诊疗方面达成共识,修订了2016年发布的《ESMO胃癌诊断、治疗和随访的临床实践指南》,以更适应对亚洲胃癌的管理和治疗。2019年ESMO转移性胃癌指南最大的更新是免疫治疗部分:①在生物标志物方面,可考虑进行微卫星不稳定和错配修复基因、程序性死亡蛋白配体1、肿瘤突变负荷以及EB病毒的检测;②在药物治疗方面,更新了免疫检查点抑制剂纳武利尤单抗、帕博丽珠单抗在晚期胃癌治疗中的应用。该指南的更新体现了胃癌进入免疫治疗时代。展开更多
目前新辅助放化疗已经逐渐变成局部进展期直肠癌的标准治疗手段之一。新辅助放化疗能使肿瘤降期,提高病理缓解率和保肛率,减少局部复发率。欧洲肿瘤内科学会（European society for medical oncology,ESMO）针对局部进展期直肠癌新辅助...目前新辅助放化疗已经逐渐变成局部进展期直肠癌的标准治疗手段之一。新辅助放化疗能使肿瘤降期,提高病理缓解率和保肛率,减少局部复发率。欧洲肿瘤内科学会（European society for medical oncology,ESMO）针对局部进展期直肠癌新辅助放化疗制定了治疗指南,并作了相关推荐。展开更多
谵妄是一种在成人肿瘤患者中常见的神经认知综合征。但在临床中,医护人员对肿瘤患者谵妄的评估、诊断不足。欧洲肿瘤学会(European Society for Medical Oncology,ESMO)于2018年发布了成人肿瘤患者谵妄临床实践指南,分7个方面进行了系...谵妄是一种在成人肿瘤患者中常见的神经认知综合征。但在临床中,医护人员对肿瘤患者谵妄的评估、诊断不足。欧洲肿瘤学会(European Society for Medical Oncology,ESMO)于2018年发布了成人肿瘤患者谵妄临床实践指南,分7个方面进行了系统的文献回顾和讨论,并就其中部分内容给出了临床实践推荐意见。本文将针对该指南中部分内容进行解读,以供临床决策与标准护理参考。展开更多
A number of very interesting studies presented this year at the ASCO (American Society of Clinical Oncology) Annual Meeting, the ASCO-GU (ASCO Genitourinary Cancers) Spring Meeting, and the ESMO (European Society for ...A number of very interesting studies presented this year at the ASCO (American Society of Clinical Oncology) Annual Meeting, the ASCO-GU (ASCO Genitourinary Cancers) Spring Meeting, and the ESMO (European Society for Medical Oncology) Annual Congress could strongly influence or even revolutionize the systemic treatment of advanced renal cell carcinoma (RCC). The aim of this article is to identify, summarize and discuss some outstanding studies of direct or indirect clinical relevance for systemic therapy.展开更多
In 2013,at the congress of the European CanCer Organization and the European Society for Medical Oncology,colorectal cancer was the subject of various oral presentations and posters.In this article,we have selected th...In 2013,at the congress of the European CanCer Organization and the European Society for Medical Oncology,colorectal cancer was the subject of various oral presentations and posters.In this article,we have selected the most innovative studies that are likely to change our daily practice.展开更多
Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication.This list is provided as a service to readers;inclusion does not imply endorsement by ...Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication.This list is provided as a service to readers;inclusion does not imply endorsement by the Hepatobiliary&Pancreatic Diseases International.June,2025 EORTC-ESMO-AACR methods in clinical cancer research workshop June 14-20,2025;Sint-Michielsgestel,the Netherlands The workshop is organized by the European Organisation for Research and Treatment of Cancer(EORTC),European Society for Medical Oncology(ESMO)and American Association for Cancer Research(AACR).展开更多
文摘2024年9月13日至17日,2024年欧洲肿瘤内科学会(European Society for Medical Oncology,ESMO)年会在西班牙巴塞罗那召开。大会公布了多项肝细胞癌(hepatocellular carcinoma,HCC)领域的重磅研究,涵盖了早期、中期、晚期HCC的治疗进展,包含系统治疗和局部治疗。这些研究将为HCC临床治疗提供新的方案并推动HCC治疗领域的发展。本文汇总此次大会的重点内容,并基于此探讨HCC相关治疗领域的问题及未来发展的方向。
文摘2018年,欧洲肿瘤内科学会(European Society for Medical Oncology,ESMO)和日本、中国、韩国等亚洲各国胃癌治疗领域的专家以科学证据为基础,在胃癌诊疗方面达成共识,修订了2016年发布的《ESMO胃癌诊断、治疗和随访的临床实践指南》,以更适应对亚洲胃癌的管理和治疗。2019年ESMO转移性胃癌指南最大的更新是免疫治疗部分:①在生物标志物方面,可考虑进行微卫星不稳定和错配修复基因、程序性死亡蛋白配体1、肿瘤突变负荷以及EB病毒的检测;②在药物治疗方面,更新了免疫检查点抑制剂纳武利尤单抗、帕博丽珠单抗在晚期胃癌治疗中的应用。该指南的更新体现了胃癌进入免疫治疗时代。
文摘目前新辅助放化疗已经逐渐变成局部进展期直肠癌的标准治疗手段之一。新辅助放化疗能使肿瘤降期,提高病理缓解率和保肛率,减少局部复发率。欧洲肿瘤内科学会（European society for medical oncology,ESMO）针对局部进展期直肠癌新辅助放化疗制定了治疗指南,并作了相关推荐。
文摘谵妄是一种在成人肿瘤患者中常见的神经认知综合征。但在临床中,医护人员对肿瘤患者谵妄的评估、诊断不足。欧洲肿瘤学会(European Society for Medical Oncology,ESMO)于2018年发布了成人肿瘤患者谵妄临床实践指南,分7个方面进行了系统的文献回顾和讨论,并就其中部分内容给出了临床实践推荐意见。本文将针对该指南中部分内容进行解读,以供临床决策与标准护理参考。
文摘A number of very interesting studies presented this year at the ASCO (American Society of Clinical Oncology) Annual Meeting, the ASCO-GU (ASCO Genitourinary Cancers) Spring Meeting, and the ESMO (European Society for Medical Oncology) Annual Congress could strongly influence or even revolutionize the systemic treatment of advanced renal cell carcinoma (RCC). The aim of this article is to identify, summarize and discuss some outstanding studies of direct or indirect clinical relevance for systemic therapy.
文摘In 2013,at the congress of the European CanCer Organization and the European Society for Medical Oncology,colorectal cancer was the subject of various oral presentations and posters.In this article,we have selected the most innovative studies that are likely to change our daily practice.
文摘Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication.This list is provided as a service to readers;inclusion does not imply endorsement by the Hepatobiliary&Pancreatic Diseases International.June,2025 EORTC-ESMO-AACR methods in clinical cancer research workshop June 14-20,2025;Sint-Michielsgestel,the Netherlands The workshop is organized by the European Organisation for Research and Treatment of Cancer(EORTC),European Society for Medical Oncology(ESMO)and American Association for Cancer Research(AACR).
